Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

This study has been completed.
Information provided by:
Abbott Identifier:
First received: January 6, 2004
Last updated: September 28, 2006
Last verified: September 2006